Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Figures corrected NBB
Corrected annual account filed for 2022.
Financials
Financial year 2025
CREO MEDICAL from Anderlecht, company number BE0443933069, closed financial year 2025 with a result of € 538,154 after tax. For that financial year CREO MEDICAL recorded a gross margin of € 2 million and equity of € 3.6 million. Compared with financial year 2024, the result moved from € 221,601 to € 538,154. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 27, 2026.
€ 3.6 million
▲ 18% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 538,154
▲ 143% vs 2024
Profit after tax over the fiscal year.
€ 1 million
▲ 78% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 3.6 million.
People and assets in 2025
9.6
▼ 1.2 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 1.3 million
▼ 3% vs 2024
€ 131,000 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 44,061
▲ 122% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 57,840
▼ 19% vs 2024
€ 7,288 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.
€ 379,751
▼ 25% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 273,737
▼ 14% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 1,459,210 | € 1,658,236 | € 1,723,475 | € 1,951,612 | ▲ 13% |
| Profit after taxes | € 382,369 | € 490,951 | € 221,601 | € 538,154 | ▲ 143% |
| Equity | € 2,346,691 | € 2,837,642 | € 3,059,243 | € 3,597,397 | ▲ 18% |
| Total debts | € 932,746 | € 709,711 | € 900,973 | € 711,328 | ▼ 21% |
| Cash | € 373,776 | € 230,219 | € 563,087 | € 1,002,803 | ▲ 78% |
| Retained profit | € 2,328,099 | € 2,819,050 | € 3,040,651 | € 3,578,805 | ▲ 18% |
| Bank debt | € 119,158 | € 120,364 | € 71,027 | € 57,840 | ▼ 19% |
| Balance sheet total | € 3,279,438 | € 3,547,353 | € 3,960,217 | € 4,308,725 | ▲ 9% |
| Employees (FTE) | 8.9 | 8.8 | 10.8 | 9.6 | ▼ 1.2 |
Key figures of CREO MEDICAL, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to CREO MEDICAL?
What happened at CREO MEDICAL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 538,154 (▲ 143% vs 2024). Source: NBB ↗
- Craig Gulliford stepped down as director. NBB
- Richard Rees stepped down as director. NBB
- Craig Gulliford became a director. NBB
- Richard Rees became a director. NBB
- Luis Ignacio Collantes Niño became a director. NBB
- New establishment in Anderlecht. KBO
- Start of the company according to the CBE. KBO
In short
From € 382,369 profit in 2022 to € 538,154 profit in 2025.
Paid € 578,819 in corporate taxes since 2022.
Best year ever: 2025, with € 538,154 profit.
On average € 203,300 of value added per employee in 2025.
A new publication or filing at CREO MEDICAL? We notify you, reason included.
Follow CREO MEDICALDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind CREO MEDICAL is Luis Ignacio Collantes Niño.
Directors
According to the 2025 annual accounts
Luis Ignacio Collantes Niño
Administrator-manager
since 2020
Craig Gulliford
Director
since 2020 · until 2025
Richard Rees
Director
since 2020 · until 2025
Establishments
Establishment units
Physical locations of this company
Veeartsenstraat 42
1070 Anderlecht
Veeartsenstraat 42D
1070 Anderlecht
Active since 9 December 2016
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 5 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0443.933.069
- VAT number
- BE 0443.933.069
- Registered office
- Veeartsenstraat 42, 1070 Anderlecht
- Names & denominations
- CREO MEDICAL · C.M.
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 25 April 1991
- Peppol
- Active · Active since 25 Feb 2026
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Groothandel in farmaceutische producten
Handelsbemiddeling in de groothandel in andere specifieke goederen
Handelsbemiddeling gespecialiseerd in overige goederen, n.e.g.